iScience (Apr 2021)

Myofiber androgen receptor increases muscle strength mediated by a skeletal muscle splicing variant of Mylk4

  • Iori Sakakibara,
  • Yuta Yanagihara,
  • Koichi Himori,
  • Takashi Yamada,
  • Hiroshi Sakai,
  • Yuichiro Sawada,
  • Hirotaka Takahashi,
  • Noritaka Saeki,
  • Hiroyuki Hirakawa,
  • Atsushi Yokoyama,
  • So-ichiro Fukada,
  • Tatsuya Sawasaki,
  • Yuuki Imai

Journal volume & issue
Vol. 24, no. 4
p. 102303

Abstract

Read online

Summary: Androgens have a robust effect on skeletal muscles to increase muscle mass and strength. The molecular mechanism of androgen/androgen receptor (AR) action on muscle strength is still not well known, especially for the regulation of sarcomeric genes. In this study, we generated androgen-induced hypertrophic model mice, myofiber-specific androgen receptor knockout (cARKO) mice supplemented with dihydrotestosterone (DHT). DHT treatment increased grip strength in control mice but not in cARKO mice. Transcriptome analysis by RNA-seq, using skeletal muscles obtained from control and cARKO mice treated with or without DHT, identified a fast-type muscle-specific novel splicing variant of Myosin light-chain kinase 4 (Mylk4) as a target of AR in skeletal muscles. Mylk4 knockout mice exhibited decreased maximum isometric torque of plantar flexion and passive stiffness of myofibers due to reduced phosphorylation of Myomesin 1 protein. This study suggests that androgen-induced skeletal muscle strength is mediated with Mylk4 and Myomesin 1 axis.

Keywords